Alembic Pharmaceuticals announced that its joint venture named Aleor Dermaceuticals received approval for Desonide Ointment, 0.05 per cent from USFDA.

Dr Reddy's Laboratories on Wednesday said that it has voluntarily recalled all its Ranitidine medicines from US market due to contamination with probable cancer causing N-Nitrosodimethylamine (NDMA).

Lupin Limited received approval for its Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Depakote Extended-Release Tablets, 250 mg and 500 mg, of AbbVie Inc.

Larsen and Toubro Hydrocarbon Engineering Limited (LTHE) on Wednesday, has been awarded a mega EPCC project by Hindustan Petroleum Corporation Limited (HPCL). LTHE is a wholly owned subsidiary of Larsen and Toubro.

Amber Enterprises India Limited on Friday informed about acquisition of Equity Share Capital of EVER Electronics Private Limited.

Karur Vysya Bank on Wednesday informed the tie up with Home Credit India (HCIN) for a unique lending partnership.

Sun Pharmaceutical Industries Limited on Monday informed the exchanges about launching of CEQUA for the treatment of dry eye disease in the US.

Morepen Laboratories Limited on Monday informed the exchanges that it has developed and added three drugs to its portfolio of Active Pharmaceutical Ingredients for sale in domestic and global markets.

Indiabulls Ventures Limited on Friday informed the exchanges on Friday that the board of directors have approved the buyback of Rs. 1000 crores of up to 6,66,66,666 fully paid-up equity shares.

Sintex Plastics Technology Limited on Thursday informed the divestment of entire equity holding in indirect wholly owned subsidiary, Sintex NP SAS.